Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study.

Autor:	Amado CA; Department of Pulmonology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.; University of Cantabria, Santander, Spain.; IDIVAL (Instituto de Investigación Biomédica de Cantabria), Santander, Spain., Martín-Audera P; Department of Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Agüero J; Department of Pulmonology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Lavín BA; Department of Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Guerra AR; Department of Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Boucle D; University of Cantabria, Santander, Spain., Ferrer-Pargada D; Department of Pulmonology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Berja A; Department of Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Martín F; Unidad de Deshabituación Tabáquica (UDESTA), Servicio Cántabro de Salud, Santander, Spain., Casanova C; Servicio de Neumología-Unidad de Investigación, Hospital Universitario La Candelaria, Universidad de La Laguna, San Cristóbal de La Laguna, Spain., García-Unzueta M; University of Cantabria, Santander, Spain.; Department of Clinical Biochemistry, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Jazyk:	angličtina
Zdroj:	Frontiers in medicine [Front Med (Lausanne)] 2023 Feb 08; Vol. 10, pp. 1100211. Date of Electronic Publication: 2023 Feb 08 (Print Publication: 2023).
DOI:	10.3389/fmed.2023.1100211
Abstrakt:	Background: MOTS-c and Romo1 are mitochondrial peptides that are modulated by oxidative stress. No previous studies have explored circulating levels of MOTS-c in patients with chronic obstructive pulmonary disease (COPD). Methods: We enrolled 142 patients with stable COPD and 47 smokers with normal lung function in an observational cross-sectional study. We assessed serum levels of both MOTS-c and Romo1 and associated these findings with clinical characteristics of COPD. Results: Compared with smokers with normal lung function, patients with COPD had lower levels of MOTS-c ( p = 0.02) and higher levels of Romo1 ( p = 0.01). A multivariate logistic regression analysis revealed that above-median MOTS-c levels were positively associated with Romo1 levels (OR 1.075, 95% CI 1.005-1.150, p = 0.036), but no association was found with other COPD characteristics. Below-median levels of circulating MOTS-c were associated with oxygen desaturation (OR 3.25 95% CI 1.456-8.522, p = 0.005) and walking <350 meters (OR 3.246 95% CI 1.229-8.577, p = 0.018) in six-minute walk test. Above-median levels of Romo1 were positively associated with current smoking (OR 2.756, 95% CI 1.133-6.704, p = 0.025) and negatively associated with baseline oxygen saturation (OR 0.776 95% CI 0.641-0.939, p = 0.009). Conclusions: Reduced levels of circulating MOTS-c and increased levels of Romo1 were detected in patients diagnosed with COPD. Low levels of MOTS-c were associated with oxygen desaturation and poorer exercise capacity using 6 min walk test. Romo1 was associated with current smoking and baseline oxygen saturation. Trial Registration: www.clinicaltrials.gov; No.: NCT04449419; URL: www.clinicaltrials.gov. Date of registration: June 26, 2020. Competing Interests: CA has received speaker or consulting fees from Boehringer Ingelheim, Pfizer, AstraZeneca, Novartis, Chiesi, Faes Farma, Esteve, and GSK. CC has received speaker or consulting fees from AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, GSK, Menarini, Novartis, and research grants from GSK, Menarini, and AstraZeneca. DF-P has received speaker or consulting fees from Chiesi and GSK. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Amado, Martín-Audera, Agüero, Lavín, Guerra, Boucle, Ferrer-Pargada, Berja, Martín, Casanova and García-Unzueta.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu